BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17628700)

  • 1. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
    Sarchielli P; Di Filippo M; Candeliere A; Chiasserini D; Mattioni A; Tenaglia S; Bonucci M; Calabresi P
    J Neuroimmunol; 2007 Aug; 188(1-2):146-58. PubMed ID: 17628700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
    Poulopoulou C; Hatzimanolis A
    J Neuroimmunol; 2008 Feb; 194(1-2):191; author reply 192. PubMed ID: 17996951
    [No Abstract]   [Full Text] [Related]  

  • 3. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
    Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration.
    Ganor Y; Besser M; Ben-Zakay N; Unger T; Levite M
    J Immunol; 2003 Apr; 170(8):4362-72. PubMed ID: 12682273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
    Sarchielli P; Greco L; Floridi A; Floridi A; Gallai V
    Arch Neurol; 2003 Aug; 60(8):1082-8. PubMed ID: 12925363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
    Bar-Or A; Vollmer T; Antel J; Arnold DL; Bodner CA; Campagnolo D; Gianettoni J; Jalili F; Kachuck N; Lapierre Y; Niino M; Oger J; Price M; Rhodes S; Robinson WH; Shi FD; Utz PJ; Valone F; Weiner L; Steinman L; Garren H
    Arch Neurol; 2007 Oct; 64(10):1407-15. PubMed ID: 17698695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens.
    Venken K; Hellings N; Hensen K; Rummens JL; Stinissen P
    J Neuroimmunol; 2010 Sep; 226(1-2):185-91. PubMed ID: 20554330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
    Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
    Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
    de Rosbo NK; Ben-Nun A
    J Autoimmun; 1998 Aug; 11(4):287-99. PubMed ID: 9776706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
    Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
    J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
    Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
    Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients.
    Achiron A; Lavie G; Kishner I; Stern Y; Sarova-Pinhas I; Ben-Aharon T; Barak Y; Raz H; Lavie M; Barliya T; Faibel M; Cohen IR; Mandel M
    Clin Immunol; 2004 Nov; 113(2):155-60. PubMed ID: 15451472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
    Salvetti M; Ristori G; D'Amato M; Buttinelli C; Falcone M; Fieschi C; Wekerle H; Pozzilli C
    Eur J Immunol; 1993 Jun; 23(6):1232-9. PubMed ID: 7684682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.